Ryman Healthcare Limited (RYHTY)
USD 12.57
(0.0%)
USD 12.57
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 650.53 Million | 560.11 Million | 503.75 Million | 452.41 Million | 422.11 Million | 381.8 Million |
| Cost of Revenue | 651.88 Million | 579.87 Million | 501.93 Million | 427.67 Million | 377.86 Million | 301.54 Million |
| Gross Profit | -1.34 Million | -19.76 Million | 1.82 Million | 24.73 Million | 44.24 Million | 80.25 Million |
| Operating Expenses | 112.6 Million | 215.54 Million | 710.18 Million | 369.37 Million | 115.82 Million | 267.58 Million |
| Selling, General and Administrative Expenses | 463.91 Million | 176.66 Million | 305.75 Million | 265.49 Million | 233.54 Million | 2.2 Million |
| Research and Development Expenses | - | 11.74 Million | 5.1 Million | 5.13 Million | 3.6 Million | - |
| Other Expenses | - | 440.23 Million | 750.88 Million | 420.12 Million | 145.66 Million | 293.76 Million |
| Cost and Expenses | 764.48 Million | 579.87 Million | 501.93 Million | 427.67 Million | 377.86 Million | 569.13 Million |
| Operating Income | -69.6 Million | -19.76 Million | 1.82 Million | 24.73 Million | 44.24 Million | 54.93 Million |
| Interest Expense | 50.39 Million | 120.07 Million | 30.66 Million | 19.36 Million | 19.3 Million | 18.95 Million |
| Income Tax Expense | -149.7 Million | -51.64 Million | 29.2 Million | -12.56 Million | -93.56 Million | 3.42 Million |
| Earnings before Tax | -144.92 Million | 206.19 Million | 722.08 Million | 410.5 Million | 171.14 Million | 329.41 Million |
| Net Income | 4.77 Million | 257.83 Million | 692.87 Million | 423.06 Million | 264.71 Million | 325.98 Million |
| Earnings Per Share Basic | 0.01 | 0.50 | 1.31 | 0.80 | 0.50 | 0.65 |
| Earnings Per Share Diluted | 0.01 | 0.50 | 1.31 | 0.80 | 0.50 | 0.65 |
| Weighted Average Shares Outstanding | 687.64 Million | 516.32 Million | 530.45 Million | 530.45 Million | 530.45 Million | 500 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.64 Million | 516.32 Million | 530.45 Million | 530.45 Million | 530.45 Million | 500 Million |
| Gross Margin | -0.00 | -0.04 | 0.00 | 0.05 | 0.10 | 0.21 |
| EBIT Margin | -0.08 | 0.05 | 0.07 | 0.13 | 0.17 | 0.20 |
| Profit Margin | 0.01 | 0.46 | 1.38 | 0.94 | 0.63 | 0.85 |
| EBITDA | -50.73 Million | 26.83 Million | 37.52 Million | 57.1 Million | 72.86 Million | 75.45 Million |
| Earnings Before Tax Margin | -0.11 | -0.04 | 0.00 | 0.05 | 0.10 | 0.14 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 650.53 Million | 365.87 Million | 316.67 Million | 290.17 Million | 560.11 Million | 269.93 Million |
| Cost of Revenue | 695.68 Million | 359.03 Million | 319.04 Million | 291.73 Million | 579.87 Million | 288.14 Million |
| Gross Profit | -45.15 Million | 6.84 Million | -2.37 Million | -1.55 Million | -19.76 Million | -18.21 Million |
| Operating Expenses | 720.14 Million | 247.62 Million | 135.02 Million | 66.87 Million | 215.54 Million | 227.56 Million |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | 16.07 Million | - | 11.74 Million | - | - |
| Other Expenses | 216.57 Million | - | - | - | 440.23 Million | - |
| Cost and Expenses | 695.68 Million | 606.65 Million | 319.04 Million | 291.73 Million | 579.87 Million | 288.14 Million |
| Operating Income | -45.15 Million | -10.77 Million | -2.37 Million | -1.55 Million | -19.76 Million | -18.21 Million |
| Interest Expense | 50.39 Million | 28.94 Million | 21.7 Million | 186.01 Million | 120.07 Million | 19.35 Million |
| Income Tax Expense | -149.7 Million | 106.45 Million | -43.25 Million | -74.95 Million | -51.64 Million | 23.31 Million |
| Earnings before Tax | -144.92 Million | -288.36 Million | 143.43 Million | -11.1 Million | 206.19 Million | 217.3 Million |
| Net Income | 4.77 Million | -181.91 Million | 186.68 Million | 63.85 Million | 257.83 Million | 193.98 Million |
| Earnings Per Share Basic | - | -0.26 | 0.27 | 0.11 | - | 0.37 |
| Earnings Per Share Diluted | - | -0.26 | 0.27 | 0.11 | - | 0.37 |
| Weighted Average Shares Outstanding | 687.64 Million | 687.64 Million | 687.64 Million | 573.17 Million | 516.32 Million | 530.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.64 Million | 687.64 Million | 687.64 Million | 573.17 Million | 516.32 Million | 530.45 Million |
| Gross Margin | -0.07 | 0.02 | -0.01 | -0.01 | -0.04 | -0.07 |
| EBIT Margin | - | -0.03 | 0.08 | 0.08 | - | 0.02 |
| Profit Margin | 0.01 | -0.50 | 0.59 | 0.22 | 0.46 | 0.72 |
| EBITDA | - | -11.13 Million | 23.81 Million | 22.04 Million | - | 4.78 Million |
| Earnings Before Tax Margin | -0.07 | -0.03 | -0.01 | -0.01 | -0.04 | -0.07 |
MELI
6098
KRP
6482
VRBFF
ATHM